Sign in to view more
Bacterial bloodstream infections in pediatric allogeneic hematopoietic stem cell recipients before and after implementation of a central line-associated bloodstream infection protocol: A single-center experience.
Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation.
A Study of Impact of Bacterial Blood Stream Infections (BBSI) and Antibiotic Resistance on Transplant Related Mortality (TRM) Following Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Children: A Multicenter Study
High Hematopoietic Transplantation Comorbidity Index Is Not Associated with Increased Transplant Related Mortality: Review of a Large Cohort of Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation Following Busulfan-Based Regimens for Malignant and Non-Malignant Diseases
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem
Higher Incidence of Treatment-Related Toxicities in Non-Hispanic Patients Undergoing Therapy for Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia on Dana-Farber Cancer Institute ALL Consortium Protocol 05-001
Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia: Risk-Adapted Upfront AlloHSCT in SAA
Incidence of and Risk Factors for Cytomegalovirus (CMV), Epstein Barr Virus (EBV) and Adenovirus (ADV) Reactivation in Pediatric Recipients Post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHCT)
Sub-Therapeutic Blood Tacrolimus Levels after Conversion from Continuous Intravenous (IV) Infusion to Per Oral (PO) are Associated with Higher Incidence of Acute Graft Versus Host Disease (AGVHD) in Children Following Allogeneic Hematopoietic Cell Transplant (AlloHCT)
The Impact of Subtherapeutic Tacrolimus Levels on the Incidence of Acute Graft-Versus Host-Disease (aGVHD) in Children Following Allogeneic Hematopoietic Cell Transplantation (AlloHCT) – Redefining the Target Range
Sequential Myeloablative Autologous Stem Cell Transplantation and Reduced Intensity Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor Risk Refractory or Recurrent Hodgkin (HL) and Non-Hodgkin Lymphoma (NHL)